Clinical Study
Kidney Dosimetry in 177Lu and 90Y Peptide Receptor Radionuclide Therapy: Influence of Image Timing, Time-Activity Integration Method, and Risk Factors
Figure 4
177Lu and for the cases in which there was a discrepancy greater than 10% between the visual and the -test (8 cases for TATE, 11 for TOC).
